RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IONS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Ionis Pharmaceuticals stock downgraded from Hold/Accumulate to Sell Candidate after Thursday trading session.
(Updated on Mar 28, 2024)

Sell candidate since Mar 28, 2024 PDF

The Ionis Pharmaceuticals stock price fell by -2.93% on the last day (Thursday, 28th Mar 2024) from $44.66 to $43.35. During the last trading day the stock fluctuated 3.76% from a day low at $43.32 to a day high of $44.95. The price has risen in 6 of the last 10 days and is up by 2.77% over the past 2 weeks. Volume has increased on the last day by 1 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $82.58 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -20.61% during the next 3 months and, with a 90% probability hold a price between $32.15 and $35.78 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IONS Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, March 18, 2024, and so far it has risen 3.14%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ionis Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $43.47 and $44.91. A break-up above any of these levels will issue buy signals. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Ionis Pharmaceuticals stock

Ionis Pharmaceuticals finds support from accumulated volume at $43.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.63 (3.76%) between high and low. For the last week, the stock has had daily average volatility of 2.65%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IONS) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Ionis Pharmaceuticals to open at $43.87, and during the day (based on 14 day Average True Range), to move between $42.11 and $44.59, which gives a possible trading interval of +/-$1.24 (+/-2.86%) up or down from last closing price. If Ionis Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 5.72% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $43.16 (0.44%) than the resistance at $44.43 (2.49%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Ionis Pharmaceuticals stock A Buy?

Ionis Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.880 Sell Candidate Downgraded

Predicted Opening Price for Ionis Pharmaceuticals of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$43.87 ( 1.21%) $43.35

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IONS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 45.50 4.97 %
R2 44.88 3.53 %
R1 44.50 2.64 %
Current price: 43.35
Support S1 43.25 -0.229 %
S2 42.87 -1.12 %
S3 42.24 -2.55 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 50.98 17.60 %
R2 45.28 4.45 %
R1 44.43 2.49 %
Current price 43.35
Support S1 43.16 -0.438%
S2 42.55 -1.85%
S3 42.18 -2.70%

FAQ

What is the symbol for Ionis Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Ionis Pharmaceuticals is IONS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ionis Pharmaceuticals Stock?
Ionis Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Ionis Pharmaceuticals Stock?
Ionis Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ionis Pharmaceuticals Stock.

What's the current price of Ionis Pharmaceuticals Stock?
As of the end of day on the 2024-03-28, the price of an Ionis Pharmaceuticals (IONS) share was $43.35.

What is the 52-week high and low for Ionis Pharmaceuticals Stock?
The 52-week high for Ionis Pharmaceuticals Stock is $54.44 and the 52-week low is $34.32.

What is the market capitalization of Ionis Pharmaceuticals Stock?
As of the 2024-03-28, the market capitalization of Ionis Pharmaceuticals is 6.318B.

When is the next earnings date for Ionis Pharmaceuticals?
The upcoming earnings date for Ionis Pharmaceuticals is May 01, 2024.
Click to get the best stock tips daily for free!

About Ionis Pharmaceuticals

Ionis Pharmaceuticals Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various... IONS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT